• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2); AHBS2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-HBS2 (AHBS2); AHBS2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/08/2019
Event Type  malfunction  
Manufacturer Narrative
A siemens customer service engineer (cse) was sent to the customer site for system inspection.The cse replaced the wash separation manifold and tested the system.Siemens healthcare diagnostics is investigating.Mdr 1219913-2019-00027 was filed for the same event (different patient).
 
Event Description
Reactive advia centaur xp anti-hbs2 (ahbs2) results were obtained for a patient sample.The patient sample was tested on an alternate method and the result was negative.A corrected report was issued.Patient treatment was not prescribed or altered.There was no report of adverse health consequences due to the anti-hbs2 results.
 
Manufacturer Narrative
Siemens filed the initial mdr 1219913-2019-00031 on (b)(6) 2019.(b)(6) 2019 additional information: the cse replaced the wash separation manifold and tested the system.A possible cause of the elevated results for this direct assay are poor aspiration of waste or system contamination.For this assay the wash separation manifold is responsible for the aspiration of unbound waste material at aspirate positions 1, 2, 3, and 4 and dispensing of wash 1 at dispense ports 1, wash displacement (wd), and 3 during the washing process.Damage to the wash separation manifold could cause elevated results.However, this could not be confirmed as the cause of the false positive results.The instrument is performing within specifications.No further evaluation of the device is required.Mdr 1219913-2019-00027 supplemental report 1 was filed for the same event (different patient).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP ANTI-HBS2 (AHBS2)
Type of Device
AHBS2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key8384261
MDR Text Key137719809
Report Number1219913-2019-00031
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414561790
UDI-Public00630414561790
Combination Product (y/n)N
PMA/PMN Number
P100039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2020
Device Model NumberN/A
Device Catalogue Number10286268
Device Lot Number93209102
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/11/2019
Initial Date FDA Received03/02/2019
Supplement Dates Manufacturer Received03/06/2019
Supplement Dates FDA Received03/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age29 YR
-
-